2'-Deoxyguanosine 5'-monophosphate-13C10,15N5 (disodium)

CAT:
804-HY-W013159S
Size:
1 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
2'-Deoxyguanosine 5'-monophosphate-13C10,15N5 (disodium) - image 1

2'-Deoxyguanosine 5'-monophosphate-13C10,15N5 (disodium)

  • UNSPSC Description:

    2'-Deoxyguanosine 5'-monophosphate-13C10,15N5 (disodium) is the 13C and 15N labeled 2'-Deoxyguanosine 5'-monophosphate disodium[1]. 2'-Deoxyguanosine 5'-monophosphate disodium (5′-dGMP disodium) is a mononucleotide having guanine as the nucleobase. 2'-Deoxyguanosine 5'-monophosphate disodium is a nucleic acid guanosine triphosphate (GTP) derivative[2].
  • Target Antigen:

    Endogenous Metabolite
  • Type:

    Isotope-Labeled Compounds
  • Related Pathways:

    Metabolic Enzyme/Protease
  • Applications:

    Metabolism-protein/nucleotide metabolism
  • Field of Research:

    Metabolic Disease
  • Assay Protocol:

    https://www.medchemexpress.com/2-deoxyguanosine-5-monophosphate-13c10-15n5-disodium.html
  • Purity:

    98.97
  • Solubility:

    10 mM in DMSO
  • Smiles:

    O=[13C]1[13C]2=[13C]([15N]([13CH]=[15N]2)[13C@@]3([H])[13C]([13C@]([13C@](O3)([13CH2]OP(O[Na])(O[Na])=O)[H])([H])O)([H])[H])[15N]=[13C]([15NH2])[15NH]1
  • Molecular Weight:

    406.08
  • References & Citations:

    [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.|[2]M Paula Denofrio, et al. The photosensitizing activity of lumazine using 2'-deoxyguanosine 5'-monophosphate and HeLa cells as targets. Photochem Photobiol Sci. 2009 Nov;8(11):1539-49.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    4°C (Powder, sealed storage, away from moisture)
  • Clinical Information:

    No Development Reported